Hemolytic disease of the newborn (ABO)

Hemolytic disease of the newborn (ABO)
Synonyms	ABO hemolytic disease of the newborn, ABO HDN
Pronounce	N/A
Specialty	N/A
Symptoms	Jaundice, anemia, hepatosplenomegaly, kernicterus
Complications	Severe anemia, heart failure, bilirubin encephalopathy
Onset	Neonatal
Duration	Varies, can be acute or chronic
Types	N/A
Causes	ABO blood group system incompatibility between mother and fetus
Risks	Maternal-fetal blood group incompatibility, previous affected pregnancies
Diagnosis	Coombs test, blood smear, bilirubin levels
Differential diagnosis	Rh disease, G6PD deficiency, spherocytosis
Prevention	Monitoring of at-risk pregnancies, phototherapy, exchange transfusion
Treatment	Phototherapy, intravenous immunoglobulin, exchange transfusion
Medication	N/A
Prognosis	N/A
Frequency	Varies, more common in certain populations
Deaths	N/A

Hemolytic Disease of the Newborn (ABO) is a condition that occurs when there is an incompatibility between the blood types of the mother and her newborn. This disease is a type of hemolytic anemia specifically caused by the ABO blood group incompatibility, which is the most common form of blood type incompatibility between mothers and their newborns. Unlike Rh disease, which is another form of hemolytic disease of the newborn but involves the Rh factor, ABO incompatibility is less severe but still requires medical attention to prevent complications.

Causes

The disease occurs when a mother's blood type is O, and her baby's blood type is either A, B, or AB. The mother's immune system may produce naturally occurring anti-A or anti-B antibodies if exposed to A or B antigens, which are foreign to her blood type. These antibodies can cross the placenta and attack the red blood cells of the fetus, leading to hemolysis (destruction of red blood cells).

Symptoms

Symptoms of Hemolytic Disease of the Newborn (ABO) can vary from mild to severe and may include jaundice, anemia, and in severe cases, hydrops fetalis. Jaundice, characterized by a yellowing of the skin and eyes, is the most common symptom and usually appears within the first 24 hours after birth.

Diagnosis

Diagnosis of Hemolytic Disease of the Newborn (ABO) involves a series of tests, including blood typing, Coombs test (direct antiglobulin test), and measuring the newborn's bilirubin levels. The Coombs test helps in detecting antibodies attached to the surface of the red blood cells, indicating an immune response against the baby's own blood cells.

Treatment

Treatment depends on the severity of the condition. Mild cases may require minimal intervention, while more severe cases might necessitate phototherapy to treat jaundice, or in extreme cases, a blood transfusion to replace the destroyed red blood cells. Early detection and treatment are crucial to prevent potential complications such as kernicterus, a form of brain damage caused by very high levels of bilirubin.

Prevention

There is no definitive way to prevent Hemolytic Disease of the Newborn (ABO), but early prenatal care and blood type screening can help manage and mitigate the risks associated with blood type incompatibilities. Pregnant women should undergo blood type testing early in pregnancy to identify potential incompatibilities with their fetus.

See Also

• Rh disease
• Anemia
• Jaundice
• Hydrops fetalis
• Kernicterus